Discover 215 paid clinical trials in Knoxville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 215
Active & Responsive
Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
Location: Knoxville TN, Columbus OH, Charlottesville VA, Richmond VA,
Sponsor: Arbor Research Collaborative for Health
Sex: All
Age: 18 - 70+
Code: NCT04970056
Recruiting
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
for
Relapsing Multiple Sclerosis (RMS)
Location: Knoxville TN, Atlanta GA, Cincinnati OH, Birmingham AL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06869785
Phase3, Recruiting
No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair
for
Postoperative Pain, Inguinal Hernia
Location: Knoxville TN, Greenville SC, Cleveland OH, Royal Oak MI,
Sponsor: Clayton Petro
Sex: All
Age: 18+
Code: NCT05929937
Recruiting
A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Knoxville TN, Charlottesville VA, Canton OH, Midlothian VA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05800015
Phase2, Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)
Sponsor: University of Tennessee Graduate School of Medicine
Sex: All
Age: 60+
Code: NCT05378659
Recruiting
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)